$RCKT

$3.57▲ +4.1% YTD

4 SEC 13D/G filings tracked · Last updated Sep 15, 2026

Filing History

RCKT ▲ +4.1% - Rocket Pharmaceuticals, Inc.

CP $3.57▲ +4.1%Sep 15, 2026 · ThinkSabio Blog

$RCKT - Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease…

News

RCKT ▲ +0.6% - Rocket Pharmaceuticals, Inc.

CP $3.45▲ +0.6%Sep 15, 2026 · ThinkSabio Blog

$RCKT Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease…

News

RCKT ▼ -0.5% - Rocket Pharmaceuticals, Inc.

CP $3.84▲ -0.5%Sep 3, 2026 · ThinkSabio Blog

$RCKT - Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences…

SEC 13D/G

$RCKT SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks Simplified

$3.09▼ -10.95%Jul 31, 2026 · ThinkSabio Blog

$RCKT SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #RCKT : $3.09 Sector: Healthcare | YTD: 🔽 -10.95% The SEC disclo…